Phase II trial of homoharringtonine with imatinib in chronic, accelerated, and blast phase chronic myeloid leukemia.

ABSTRACT:

SUBMITTER: Maiti A 

PROVIDER: S-EPMC5478443 | biostudies-literature | 2017 Sep

REPOSITORIES: biostudies-literature